Patient P-02628
Synthetic patientMETA-24 · Day 174 · 45–54 · F · baseline S14Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Stable
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
96%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S14
- Day 69 Trajectory diverged from prediction — Observed response fell below the model's expected path.
- Day 71 SC-12 recommended — Supportive Compound SC-12
- Day 72 Patient accepted — Started SC-12 in the companion
- Day 78 GI symptom burden −18% vs expected — Supportive Compound SC-12
- Day 84 Tolerance state changed — Unstable → Improving
What changed?
Trajectory began diverging from predicted response on Day 69.
Primary contributors, last 14 days
- GI instability+6
- Inflammatory activity+2
What helped?
- Supportive Compound SC-12Day 71Result: symptom burden −18%
LIFE OS recommendation
GI Support Protocol GI-04
92%
probability of meaningful tolerance improvement
- 284 similar trajectories
- 89% showed improvement
- median effect visible after 8 days
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable5 min
stable · +0.3 vs previous 14 d
Sleep duration
Wearable5.6 h
improving · +0.3 vs previous 14 d
Energy level
Daily log2.4/10
improving · +0.3 vs previous 14 d
Steps
Wearable955
worsening · -32 vs previous 14 d
GI burden
Companion63.3/100
stable · -2.5 vs previous 14 d
Adherence
Companion50.6 %
stable · +0.3 vs previous 14 d
Sleep quality
Wearable15.5/100
improving · +2.9 vs previous 14 d
Glucose, CGM daily mean
CGM155 mg/dL
stable · -0.6 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 26 from the failing basin, 66 from restoration.
Would help
- GI-04 GI Support Protocol77% improved among 65 similar · onset 8 d · confidence 93%
- ME-01 Monitoring Escalation100% improved among 42 similar · onset 3 d · confidence 70%
- NP-02 Dietary Support Protocol59% improved among 32 similar · onset 10 d · confidence 70%
- More proteinGI -4.4 next day on high-intake days · n 21
Would not help
- Keep fat lowGI +3.6 next day on high-intake days · n 23
- Keep ultra-processed lowGI +3.5 next day on high-intake days · n 18
- Keep simple carbs lowGI +3 next day on high-intake days · n 18
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-4.4supporter · 95%
- Dietary fat load+3.6detractor · 95%
- Ultra-processed food+3.5detractor · 95%
- Simple carbohydrates+3detractor · 89%
- Alcohol-1.5no signal · 40%
- Histamine load-1.2no signal · 37%
- Caffeine-0.4no signal · 15%
- Insoluble fibre0no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Inflammatory signalling ↑65
- DNAIL6 -174 variant raises baseline inflammatory tone
- BloodInflammatory load index 58
- WearableHRV 35 ms, trending down
- Autonomic recovery ↓65
- WearableResting HR 73 bpm
- Wearable955 steps/day
- WearableShort sleep window
- Mucosal barrier integrity ↓60
- MicrobiomeAkkermansia low → thinner mucus layer
- Daily logGI symptom score 63 and rising
- WearableSleep 5.6 h, below personal baseline
- Butyrate / short-chain fatty acid production ↓55
- MicrobiomeButyrate capacity 39/100
- Daily logFibre intake low in recent food logs
- Drug metabolism and exposure ↑20
- BloodToxicity index 44
DNA
Fictional pharmacogenomic panel
- IL6 -174 G/CHigher inflammatory tone
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 2.2 · butyrate capacity 39/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 37 ms
- Sleep
- 5.8 h
- Steps
- 680
- Resting HR
- 74 bpm
Daily log: GI score 63, nutritional resilience 41, adherence 51.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
- Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Track each bowel movement today: time, stool form, urgency, overnight waking
- A 15-minute walk after lunch
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- Electrolyte solution, one sachet after any loose stool
- Fictional demo item: oral nutrition supplement with lunch
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02348 | 56% | S14 | GI-04 | improved | 49 |
| P-02535 | 56% | S14 | SC-12 | improved | 50 |
| P-02320 | 55% | S14 | NP-02 | improved | 50 |
| P-02516 | 55% | S14 | SC-12 | improved | 51 |
| P-02574 | 55% | S14 | ME-01 | improved | 45 |
| P-02657 | 54% | S14 | — | — | 42 |
| P-02014 | 52% | S14 | GI-04 | improved | 48 |
| P-02316 | 51% | S14 | GI-04 | improved | 51 |
| P-02057 | 50% | S14 | GI-04 | improved | 47 |
| P-02253 | 50% | S14 | NP-02 | no change | 41 |
| P-02670 | 50% | S14 | SC-12 | improved | 45 |
| P-02059 | 49% | S03 | SC-12 | improved | 41 |